CONSHOHOCKEN, Pa., July 8 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical research services, completed a landmark research survey of over 205 clinical researchers in 18 countries who administer psychometric rating scales to measure the improvement or worsening of symptoms in psychiatric and neurologic clinical trials.
A few survey highlights include:
82% of raters surveyed prefer to be trained by scale author or someone expert in the field. 85% of raters surveyed agreed that independent monitoring of scale data during study improved accuracy and maintains rater calibration throughout the study. 90% of raters feel interview skills training prior to site activation helps improve the ability to accurately rate subjects. "While some of the results were quite fascinating and provide much better insight into the global needs of site raters, other results were consistent with what we have experienced and anticipated," stated Dr. Theresa Bromley, ePharmaSolutions' Associate Director of Rater Services. "For example, we knew that most raters would rather be certified annually than be required to train for each individual study but we didn't anticipate the overwhelming dissatisfaction with the central video interviewing solutions that seem to have disassociated the rater from the study."
ePharmaSolutions' conducts several research surveys with Investigative sites every year to help improve site adoption of its technologies and services. A formal analysis of the results are shared with ePharmaSolutions' clients and the survey respondents upon request. This year, the results can be discussed with Dr. Theresa Bromley at Booth #623 of the Annual ICAD Meeting in Honolulu, Hawaii or by email request to [email protected] .
"Through the leadership of Drs. Bromley and Ormont, ePharmaSolutions has been able to develop several industry-leading technologies and services that help reduce scoring and administrative errors at the point of care, improve rater certification/calibration, and provide secondary independent assessments at a fraction of the time and cost of available solutions," stated Lance Converse, ePharmaSolutions' Founder and CEO. "RaterPoint, our innovative suite of solutions for secondary independent assessment and point of care scoring, will also be demonstrated at ICAD," Converse continued.
About ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of niche clinical services that help improve the way sites are selected, trained, activated and supported to commence clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 185,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world. ePharmaSolutions is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com.
SOURCE ePharmaSolutions
Advertisement
A few survey highlights include:
82% of raters surveyed prefer to be trained by scale author or someone expert in the field. 85% of raters surveyed agreed that independent monitoring of scale data during study improved accuracy and maintains rater calibration throughout the study. 90% of raters feel interview skills training prior to site activation helps improve the ability to accurately rate subjects. "While some of the results were quite fascinating and provide much better insight into the global needs of site raters, other results were consistent with what we have experienced and anticipated," stated Dr. Theresa Bromley, ePharmaSolutions' Associate Director of Rater Services. "For example, we knew that most raters would rather be certified annually than be required to train for each individual study but we didn't anticipate the overwhelming dissatisfaction with the central video interviewing solutions that seem to have disassociated the rater from the study."
Advertisement
ePharmaSolutions' conducts several research surveys with Investigative sites every year to help improve site adoption of its technologies and services. A formal analysis of the results are shared with ePharmaSolutions' clients and the survey respondents upon request. This year, the results can be discussed with Dr. Theresa Bromley at Booth #623 of the Annual ICAD Meeting in Honolulu, Hawaii or by email request to [email protected] .
"Through the leadership of Drs. Bromley and Ormont, ePharmaSolutions has been able to develop several industry-leading technologies and services that help reduce scoring and administrative errors at the point of care, improve rater certification/calibration, and provide secondary independent assessments at a fraction of the time and cost of available solutions," stated Lance Converse, ePharmaSolutions' Founder and CEO. "RaterPoint, our innovative suite of solutions for secondary independent assessment and point of care scoring, will also be demonstrated at ICAD," Converse continued.
About ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of niche clinical services that help improve the way sites are selected, trained, activated and supported to commence clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 185,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world. ePharmaSolutions is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com.
SOURCE ePharmaSolutions
